About 3 results found for searched term "Codrituzumab" (0.357 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24630 | Codrituzumab | Others |
| GC33 RO5137382 | ||
| Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. | ||
| M58974 | Codrituzumab-MMAE (CHO) | Antibody-Drug Conjugates (ADCs) |
| Codrituzumab-MMAE is an antibody-drug conjugate (ADC). Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). | ||
| M58983 | Denintuzumab-MMAF | Antibody-Drug Conjugates (ADCs) |
| Anti-CD19 Reference Antibody | ||
| Denintuzumab-MMAF is an antibody-drug conjugate (ADC). Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab binds to CD19 on the surface of B cells. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
